News

AddToAny

Google+ Facebook Twitter Twitter

HOW WELL DO CANCER DRUGS HIT THEIR TARGETS?

Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets in the body.

It shows individual cancer cells in a tumour in real time, revealing which cells interact with the drug and which cells the drug fails to reach.

The findings could potentially help clinicians decide the best course and delivery of treatment for cancer patients.

Researchers at the Francis Crick Institute and Imperial College London developed the means to measure and visualise drug-target engagement of individual cells within a tumour, using a miniature fluorescent microscope.

Using their technique, they mapped out how the chemotherapy drug doxorubicin targeted ovarian cancer cells in living mice.

They found significant variation in drug-target engagement between cells within a single tumour, and between different tumours.

They also found that drug-target engagement was better when doxorubicin was administered via abdominal injection rather than intravenously – the currently preferred method for doctors treating patients in many clinics.

Erik Sahai, senior author, said: “Our findings show that in a mouse model with delivery of doxorubicin through the blood, it does not reach all its target cells in the body, which could help explain why this chemotherapy drug is only partially effective in some cancer patients.

“In contrast, delivering the drug directly into the abdomen adjacent to ovarian tumours improved its target engagement, but this was still not sufficient to kill the cancer cells.”

Click here to find out more.

 

Related Articles

“CANCEROUS CELLS WORK TOGETHER TO INFILTRATE THE BRAIN”

Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain.

MAGNETS ISOLATE CIRCULATING TUMOUR CELLS

Scientists claim that magnets could be used in the body to detect tumour cells that other diagnostic techniques might miss.

my ibms Microscopic of koilocyte cell criteria of hpv human papilloma virus infection pap smear shutterstock

HPV primary screening

Following a review of its delivery strategy, NHS England has agreed to begin a one-stage procurement process to reconfigure provider laboratories to support the roll-out of Human Papilloma Virus (HPV) primary screening into the NHS Cervical Cancer Screening Programme in England.

Dr. Alan Friedman Performs a Glioblastoma Biopsy at Duke University Hospital

Poliovirus therapy for recurrent glioblastoma

A genetically modified poliovirus therapy shows significantly improved long-term survival for patients with recurrent glioblastoma.

Top